Healthcare ❯ Pharmaceutical Industry

Drug Manufacturing

Quality Control Research and Development Obesity Treatments Approval Process Tariffs Impact Gene Therapy Weight Loss Medications Corporate Investment Neuroscience Weight Loss Drugs Injectable Medicines Biologics NHS Quality Assurance U.S. Market Research U.S. Manufacturing Investment Plans Regulatory Environment

Eli Lilly Chooses Pennsylvania for $3.5 Billion Plant to Produce Weight-Loss Injectables

The Fogelsville site completes Lilly's four-plant U.S. expansion to bolster supply resilience.

AstraZeneca Strikes White House Drug-Price Deal, Wins Three-Year Tariff Reprieve

AstraZeneca Breaks Ground on $4.5 Billion Virginia Plant With Expanded Cancer and Obesity Drug Production

AbbVie to Build $195 Million API Facility in North Chicago